Vivos Therapeutics, Inc. (VVOS)

0.27 -0.01 (-2.46%) USD  |  NASDAQ  |  Aug 25, 09:32
More

Vivos Therapeutics EPS Estimates for Next Fiscal Year

EPS Estimates for Next Fiscal Year Chart

View EPS Estimates for Next Fiscal Year for VVOS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Next Fiscal Year Chart
Start Trial

Historical EPS Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
August 19, 2026 --
July 08, 2026 --
June 04, 2026 --
May 27, 2026 --
April 17, 2026 --
December 03, 2025 --
November 17, 2025 --
September 09, 2025 --
August 21, 2025 --
May 20, 2025 --
Date Value
April 15, 2025 --
April 01, 2025 --
November 19, 2024 --
August 20, 2024 --
May 20, 2024 --
April 08, 2024 --
November 17, 2023 --
August 30, 2023 --
June 15, 2023 --
April 08, 2023 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Fiscal Year Range, Past 5 Years

View EPS Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Fiscal Year Benchmarks

View EPS Estimates for Next Fiscal Year Benchmarks
Start Trial
Hinge Health, Inc. Upgrade
Exlites Holdings International, Inc. --
Xcelerate, Inc. --
Haemonetics Corp. Upgrade
Pro-Dex, Inc. Upgrade

EPS Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade